Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have spe…
Biotechnology
US, Boston [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2023 | 4 | $6,000,000 | LD-2 : 01/22/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/22/24 |
| 2023 | 4 | $3,000,000 | LD-2 : 01/20/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/19/24 |
| 2023 | 4 | $8,000,000 | LD-2 : 01/18/24 |
Get PRO Today
With PRO you will unlock 16 more lobbying disclosures for Vertex Pharmaceuticals Incorporated